₹ 11.9 Cr
Volume transacted
434.7 K
stocks traded
Last Updated time: 19 Sep 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
19 Sep 2024 | 274.25 | 282.7 | 289 | 271.85 |
18 Sep 2024 | 281.25 | 296 | 298.7 | 277.2 |
17 Sep 2024 | 296.25 | 294.65 | 297.95 | 284.95 |
16 Sep 2024 | 293.85 | 281.95 | 296.8 | 280 |
13 Sep 2024 | 277.35 | 270.25 | 284.3 | 268.5 |
12 Sep 2024 | 268.1 | 274.25 | 274.95 | 266.85 |
11 Sep 2024 | 272.85 | 265.3 | 276 | 261.1 |
10 Sep 2024 | 263.5 | 262.7 | 273.15 | 259.3 |
09 Sep 2024 | 258.5 | 266.45 | 266.45 | 255.5 |
06 Sep 2024 | 263 | 267.95 | 278.4 | 261.8 |
Date | Price |
---|---|
19 Sep 2024 | 274.25 |
18 Sep 2024 | 281.25 |
17 Sep 2024 | 296.25 |
16 Sep 2024 | 293.85 |
13 Sep 2024 | 277.35 |
12 Sep 2024 | 268.1 |
11 Sep 2024 | 272.85 |
10 Sep 2024 | 263.5 |
09 Sep 2024 | 258.5 |
06 Sep 2024 | 263 |
Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...
Read more
21 Aug 202420:00
Marksans Pharma's Verna unit successfully completes USFDA inspection
Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...
Read more
20 Aug 202414:37
Marksans Pharma to convene AGM
Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be hel...
Read more
20 Aug 202410:46
Marksans Pharma gets EIR from USFDA for Goa facility
The inspection has been classified as voluntary action indicated (VAI) and has been closed...
Read more
20 Aug 202414:48
Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr
Revenue from operations jumped 18.12% YoY to Rs 590.62 crore in first quarter of FY25, dri...
Read more
14 Aug 202412:04
Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets
Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...
Read more
02 Aug 202416:12
FAQs for EPS of Marksans Pharma Ltd
On what factors does the shareholding pattern of Marksans Pharma Ltd change frequently?
How often is Marksans Pharma Ltd's shareholding pattern updated?
What categories are included in the shareholding pattern of Marksans Pharma Ltd?
Why is the shareholding pattern of Marksans Pharma Ltd important for investors?
Where can I find the latest shareholding pattern of Marksans Pharma Ltd?
Unlimited trading at just
Rs. 199*